These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31704314)

  • 1. Can the emerging field of immunometabolism provide insights into neuroinflammation?
    Lynch MA
    Prog Neurobiol; 2020 Jan; 184():101719. PubMed ID: 31704314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia-Specific Metabolic Changes in Neurodegeneration.
    Aldana BI
    J Mol Biol; 2019 Apr; 431(9):1830-1842. PubMed ID: 30878483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
    Kwon HS; Koh SH
    Transl Neurodegener; 2020 Nov; 9(1):42. PubMed ID: 33239064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging microglial activation during neuroinflammation and Alzheimer's disease.
    Venneti S; Wiley CA; Kofler J
    J Neuroimmune Pharmacol; 2009 Jun; 4(2):227-43. PubMed ID: 19052878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary Restriction and Neuroinflammation: A Potential Mechanistic Link.
    Bok E; Jo M; Lee S; Lee BR; Kim J; Kim HJ
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches.
    Ahmad MH; Fatima M; Mondal AC
    J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.
    Makarava N; Chang JC; Molesworth K; Baskakov IV
    Neurobiol Dis; 2020 Apr; 137():104783. PubMed ID: 32001329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.
    Baik SH; Kang S; Lee W; Choi H; Chung S; Kim JI; Mook-Jung I
    Cell Metab; 2019 Sep; 30(3):493-507.e6. PubMed ID: 31257151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytes and neuroinflammation in Alzheimer's disease.
    Phillips EC; Croft CL; Kurbatskaya K; O'Neill MJ; Hutton ML; Hanger DP; Garwood CJ; Noble W
    Biochem Soc Trans; 2014 Oct; 42(5):1321-5. PubMed ID: 25233410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network-wide dysregulation of calcium homeostasis in Alzheimer's disease.
    Brawek B; Garaschuk O
    Cell Tissue Res; 2014 Aug; 357(2):427-38. PubMed ID: 24553999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P.
    Burmeister AR; Johnson MB; Chauhan VS; Moerdyk-Schauwecker MJ; Young AD; Cooley ID; Martinez AN; Ramesh G; Philipp MT; Marriott I
    J Neuroinflammation; 2017 Dec; 14(1):245. PubMed ID: 29237453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
    Regen F; Hellmann-Regen J; Costantini E; Reale M
    Curr Alzheimer Res; 2017; 14(11):1140-1148. PubMed ID: 28164764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation.
    Jha MK; Jo M; Kim JH; Suk K
    Neuroscientist; 2019 Jun; 25(3):227-240. PubMed ID: 29931997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia and lipids: how metabolism controls brain innate immunity.
    Chausse B; Kakimoto PA; Kann O
    Semin Cell Dev Biol; 2021 Apr; 112():137-144. PubMed ID: 32807643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunometabolic reprogramming of microglia in Alzheimer's disease.
    Chen H; Guo Z; Sun Y; Dai X
    Neurochem Int; 2023 Dec; 171():105614. PubMed ID: 37748710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation: Integrated Nervous Tissue Response through Intercellular Interactions at the "Whole System" Scale.
    Nosi D; Lana D; Giovannini MG; Delfino G; Zecchi-Orlandini S
    Cells; 2021 May; 10(5):. PubMed ID: 34068375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model.
    Guedes JR; Custódia CM; Silva RJ; de Almeida LP; Pedroso de Lima MC; Cardoso AL
    Hum Mol Genet; 2014 Dec; 23(23):6286-301. PubMed ID: 24990149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer's progression.
    Codocedo JF; Mera-Reina C; Bor-Chian Lin P; Fallen PB; Puntambekar SS; Casali BT; Jury-Garfe N; Martinez P; Lasagna-Reeves CA; Landreth GE
    Cell Rep; 2024 Jul; 43(7):114488. PubMed ID: 39002124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
    Webers A; Heneka MT; Gleeson PA
    Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease.
    Lynch MA
    Immunology; 2014 Mar; 141(3):292-301. PubMed ID: 23876085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.